Sudden death prevented in hypertrophic cardiomyopathy

Heart Lung and Circulation

Volumn 12, Issue 3, 2003, Pages 196-198

  Jayatilleke, Irandi ^a   McGuire, Mark ^a   Booth, Virginia ^a   Richmond, David R ^a   Semsarian, Christopher ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b CENTENARY INSTITUTE   (Australia)

Author keywords

Cardioverter defibrillator; Hypertrophic cardiomyopathy; Sudden death

Indexed keywords

ADULT; AGE; ANGINA PECTORIS; ARTICLE; ATHLETE; CARDIOVERSION; CASE REPORT; CLINICAL EXAMINATION; COMPETITIVE BEHAVIOR; DEFIBRILLATOR; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FATIGUE; FOLLOW UP; HEART LEFT VENTRICLE WALL; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INHERITANCE; MALE; MEDICAL DECISION MAKING; PATIENT SELECTION; PRIORITY JOURNAL; RISK ASSESSMENT; SUDDEN DEATH;

EID: 0346270270     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1443-9506.2003.00183.x     Document Type: Article

References (10)

1. Semsarian C, Maron BJ. Sudden cardiac death in the young. Med. J. Aust. 2002; 176: 148-9.
2. Maron BJ, Shirani J, Poliac LC et al. Sudden death in young competitive athletes - clinical, demographic and pathological profiles. JAMA 1996; 276: 199-204.
3. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N. Engl. J. Med. 1997; 336: 775-85.
4. Semsarian C, Seidman CE. Molecular medicine in the 21st century. Intern. Med. J. 2001; 31: 53-9.
5. Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997; 350: 127-33.
6. Maron BJ, Savage DD, Wolfson JK et al. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am. J. Cardiol. 1981; 48: 252-7.
7. Spirito P, Bellone P, Harris KM et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N. Engl. J. Med. 2000; 15: 1778-85.
8. Elliott PM, Poloniecki J, Dickie S et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J. Am. Coll. Cardiol. 2000; 36: 2212-18.
9. Maron BJ, Shen W, Link MS et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N. Engl. J. Med. 2000; 342: 365-73.
10. Elliot PM, Gimeno Blanes JR et al. Relation between severity of left ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 2001; 357: 420-24.